Search

King’s College London announced that it has entered an exclusive licence agreement with UCB that grants the company the rights to develop a peptide-based immunotherapy programme for type 1 diabetes.

More efficient medical treatments could be developed thanks to a new method for triggering the rearrangement of chemical particles.

Accusations fly as the European Commission releases details of the money its €315B investment plan will take out of the EU’s Horizon 2020 kitty. The European Institute of Innovation and Technology faces the deepest cut

With the post of EU chief science adviser axed, Research Commissioner Carlos Moedas is to look at new ways of providing independent scientific inputs to policymaking. A list of the options will be presented before the summer, he tells Science|Business

While other social media networks for researchers are about showing off publications or keeping tabs on impact metrics, Piirus makes introductions. This is the way to find your perfect partner – for research, says Piirus founder Fiona Colligan

CERN is getting ready to switch on its massive underground collider again. The Higgs boson, the standout discovery of the last few years, is in the bag, so what are physicists looking for now?

The President of Singapore today laid foundation stones to mark the development of two buildings for the Lee Kong Chian School of Medicine.

The MED-EU strategic project aims to raise EU funds for scientific research and innovation. The project is coordinated by the University of Bologna and a few clinical institutes such as the S.Orsola-Malpighi University Hospital, the Rizzoli Institute for Orthopedics and the Institute for Neurologic Sciences of the Bellaria hospital.

Breakthroughs in renewable energy don’t come from Eureka moments in the laboratory, but from long term effort and investment to push nascent technologies to the point of cost efficiency, says Carlos Härtel, GE’s head of R&D in Europe

Dr. Gilbert Lenssen, ABIS' Founding President: "I am confident that Sauquet will lead the network with great strength and support from its members"

Fluidic Analytics Limited, a spinout from the University of Cambridge, has raised £1.56 million (US$2.4 million) in a Series A financing led by Cambridge Enterprise and including DFJ Esprit, IQ Capital, Parkwalk Advisors and Amadeus Capital Partners as co-investors.

A total of 277 SMEs will get funding to help get promising commercial ideas up and running. Companies from Spain, Italy, the UK, the Netherlands and France did well, but the success rate is low overall

The Bloodhound car will be a 1,000mph machine that is part spaceship, part jet fighter and part racing car. This is not a big vanity project but an engineering adventure designed to stir a new generation, says Mark Elvin

As the EU lays out some of its hoped-for outcomes from controversial EU-US trade talks in pharma, medical devices, energy and other fields, the European Ombudsman insists more transparency is needed

Science|Business makes some guesses at what research and innovation topics are likely to be among the most discussed in 2015.

Allowing academics to move their pensions from country-to-country when taking up jobs at institutions across the EU has broad support. But there is a swathe of technical and legal detail to sort out and universities need to sign up

ESADE will develop educational offerings specifically designed to strengthen the executive and leadership skills of digital entrepreneurs

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.